Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 20 | 4 | UROLOGY & NEPHROLOGY//GASTROENTEROLOGY & HEPATOLOGY//UROL | 479829 |
| 138 | 3 | HELICOBACTER PYLORI//GASTROENTEROLOGY & HEPATOLOGY//GASTROESOPHAGEAL REFLUX DISEASE | 66701 |
| 976 | 2 | REBAMIPIDE//GASTRIC ULCER//GASTROPROTECTION | 10910 |
| 33059 | 1 | ZINC ACEXAMATE//ZINC HYDROASPARTATE//ACEXAMIC ACID | 143 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ZINC ACEXAMATE | authKW | 881586 | 6% | 50% | 8 |
| 2 | ZINC HYDROASPARTATE | authKW | 293863 | 1% | 67% | 2 |
| 3 | ACEXAMIC ACID | authKW | 220399 | 1% | 100% | 1 |
| 4 | ANTI INFLAMMATORY ANTI ULCEROGENIC ANALGESIC ACTIVITY | authKW | 220399 | 1% | 100% | 1 |
| 5 | CASTRIC LESIONS | authKW | 220399 | 1% | 100% | 1 |
| 6 | CHIEF CELL RNA | authKW | 220399 | 1% | 100% | 1 |
| 7 | CIECIAS FARMACEUT | address | 220399 | 1% | 100% | 1 |
| 8 | DICLOFENAC ZINC COMPLEX | authKW | 220399 | 1% | 100% | 1 |
| 9 | FARMACOL TORRENTE VIDALET 29 | address | 220399 | 1% | 100% | 1 |
| 10 | FIBRINOGEN IL 6 | authKW | 220399 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Gastroenterology & Hepatology | 1318 | 29% | 0% | 41 |
| 2 | Pharmacology & Pharmacy | 351 | 30% | 0% | 43 |
| 3 | Medicine, Research & Experimental | 44 | 8% | 0% | 11 |
| 4 | Medicine, General & Internal | 38 | 9% | 0% | 13 |
| 5 | Microscopy | 21 | 1% | 0% | 2 |
| 6 | Biochemistry & Molecular Biology | 9 | 11% | 0% | 16 |
| 7 | Endocrinology & Metabolism | 8 | 4% | 0% | 6 |
| 8 | Biology | 8 | 3% | 0% | 4 |
| 9 | Behavioral Sciences | 7 | 2% | 0% | 3 |
| 10 | Cell Biology | 4 | 5% | 0% | 7 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CIECIAS FARMACEUT | 220399 | 1% | 100% | 1 |
| 2 | FARMACOL TORRENTE VIDALET 29 | 220399 | 1% | 100% | 1 |
| 3 | PHARMACOL PSYCHIAT PHARMACOL | 220399 | 1% | 100% | 1 |
| 4 | PRODUTOS FARMACEUT TOXICOL | 220399 | 1% | 100% | 1 |
| 5 | VAHDAT HLTH CARE | 220399 | 1% | 100% | 1 |
| 6 | HUMAN NUTR PUBL HLTH | 55098 | 1% | 25% | 1 |
| 7 | ANALYT TOXICOL THER EUT DRUG MONITORING | 24487 | 1% | 11% | 1 |
| 8 | RADIOLIGANDS | 15739 | 1% | 4% | 2 |
| 9 | CHANG HAI HOSP | 7598 | 1% | 3% | 1 |
| 10 | DRUG RUMENT CONTROL | 7108 | 1% | 3% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 6480 | 12% | 0% | 17 |
| 2 | DRUG-NUTRIENT INTERACTIONS | 2753 | 1% | 1% | 1 |
| 3 | AMERICAN JOURNAL OF PROCTOLOGY GASTROENTEROLOGY & COLON & RECTAL SURGERY | 2531 | 1% | 1% | 1 |
| 4 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1742 | 3% | 0% | 5 |
| 5 | METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 1348 | 3% | 0% | 4 |
| 6 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 1324 | 5% | 0% | 7 |
| 7 | DIGESTION | 1064 | 3% | 0% | 4 |
| 8 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 874 | 2% | 0% | 3 |
| 9 | VESTNIK ROSSIISKOI AKADEMII MEDITSINSKIKH NAUK | 748 | 1% | 0% | 1 |
| 10 | ACTA PHYSIOLOGICA HUNGARICA | 731 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |